Athena Feminine Technologies

What Athena Feminine Technologies does

Athena Feminine Technologies is a privately held medical device company headquartered in Orinda, California, operating with a small team of 1–10 employees and led under a 'for women, by women' executive model. Founded in 1996 with a stated mission to improve women's quality of life by addressing female pelvic and reproductive health concerns, the company is presently focused on a single core product, the Athena Pelvic Muscle Trainer (PMT), targeted at adult women suffering from stress, urge, or mixed urinary incontinence.

The Athena PMT is an FDA Cleared electrical vaginal stimulator that uses Pelvic Floor Electrical Stimulation (PFES) technology to deliver mild electrical currents that automatically induce pelvic floor muscle contractions and relaxations, effectively performing Kegel exercises on the user's behalf. The patented wireless system consists of two components: a vaginal trainer containing a sealed battery and a wireless controller/cradle that adjusts contraction strength, and the company explicitly positions it as the only patented-wireless PFES device on the market. The product is indicated for three target segments—athletic women experiencing exercise-induced incontinence, new mothers with post-partum pelvic floor weakness, and postmenopausal women with age-related pelvic floor decline—and is supported by citations from the American College of Obstetricians and Gynecologists (ACOG) and the American Physical Therapy Association (APTA).

The company employs a direct-to-consumer go-to-market model through its corporate website (athenaft.com), where interested buyers are routed to a contact form for inquiries because the product is currently listed as 'Coming Soon' with no public pricing. Revenue mechanics are a one-time hardware sale of the PMT device with no subscription or services component disclosed, and there are no retail, third-party, or app-based distribution channels. The company targets a US addressable market of approximately 18 million women affected by pelvic floor disorders, with an articulated mission of worldwide reach, and its only disclosed capital event to date is a $2.0 million round led by vSpring Capital in September 2009.

Name

Athena Feminine Technologies

Legal name

Athena Feminine Technologies, Inc.

Website

https://athenaft.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Athena Feminine Technologies is a privately held medical device company developing the FDA Cleared Athena Pelvic Muscle Trainer, a patented wireless Pelvic Floor Electrical Stimulation device for at-home treatment of urinary incontinence in women, sold direct-to-consumer.

Ownership category

akta.pro rank

Product category

Women's Pelvic Health Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

Pelvic Floor Physical Therapy (Women’s & Men’s Health) (HSADAIAG)

Keywords

• Pelvic floor stimulation
• Incontinence treatment devices
• Womens health devices
• Electrical muscle stimulation
• Pelvic rehabilitation

Headquarters

HQ city

Orinda

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Athena Pelvic Muscle Trainer (PMT) Device Sales: The company generates revenue from the sale of its hardware device, the Athena Pelvic Muscle Trainer. This is a one-time hardware purchase model where customers buy the PMT device for home use. The device includes the vaginal trainer and wireless controller. No recurring subscription fees are mentioned; the company emphasizes patients can maintain strength even after treatment is completed using the same device.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Athena Feminine Technologies develops and sells the Athena Pelvic Muscle Trainer (PMT), a patented-wireless FDA Cleared Pelvic Floor Electrical Stimulation (PFES) medical device for home use. The device delivers mild electrical current via a vaginal trainer with a sealed battery to induce pelvic muscle contractions, automatically performing Kegel exercises to treat stress, urge, and mixed urinary incontinence in adult women across life stages.

Product overview

Athena Feminine Technologies offers a single core product: the Athena Pelvic Muscle Trainer (PMT). This is a patented-wireless Pelvic Floor Electrical Stimulation device designed for home use to treat urinary incontinence in women. The system comprises two parts—a vaginal trainer with an integrated sealed battery and a wireless controller/cradle—and uses mild electrical currents to automatically contract and relax pelvic floor muscles, mimicking Kegel exercises. The product is FDA Cleared and targets women across different life stages including athletes, new mothers, and postmenopausal women.

Differentiator

Problem solved

Functional benefit

Brands

• Athena Pelvic Muscle Trainer (PMT): The only patented-wireless Pelvic Floor Electrical Stimulation (PFES) device that delivers mild electrical stimulation to pelvic floor muscles to make them contract and relax. FDA Cleared electrical vaginal stimulator for treatment of stress, urge, and mixed urinary incontinence in women.

Products and services

• Athena Pelvic Muscle Trainer (PMT) The Athena Pelvic Muscle Trainer (PMT) is the only patented-wireless Pelvic Floor Electrical Stimulation (PFES) device that delivers mild electrical stimulation to pelvic floor muscles to induce automatic Kegel-style contractions and relaxations. The system comprises a vaginal trainer with a sealed battery and a wireless controller/cradle that adjusts contraction strength, providing a non-invasive, drug-free home treatment for stress, urge, and mixed urinary incontinence in adult women, including athletes, new mothers, and postmenopausal women.

Quantifiable outcome

• No side effects reported, unlike pharmaceutical treatments or invasive procedures
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Perifit: Perifit makes app-connected intravaginal Kegel trainers with biofeedback for pelvic-floor strengthening and incontinence. It directly overlaps with Athena's target customer (women with weak pelvic floor) and channel (DTC), though it competes on engagement/app rather than clinical PFES.
• Elvie: Elvie (Chiaro Technology) sells the Elvie Trainer, a connected pelvic-floor Kegel trainer, and has expanded into women's health hardware. It targets the same female consumer seeking at-home pelvic-floor strengthening, though via biofeedback-based Kegel training rather than electrical stimulation.
• InControl Medical: InControl Medical makes FDA-cleared intravaginal stimulation devices (e.g., Apex) for female urinary incontinence, sold both DTC and via clinicians. It is a direct clinical competitor to Athena, with overlapping PFES mechanism and FDA-cleared UI indications.
• TensCare: TensCare manufactures a range of electrotherapy devices including pelvic-floor electrical stimulators (e.g., iTouch Sure) for urinary incontinence. It overlaps with Athena on PFES technology and clinical use case, primarily sold through medical device retailers and online channels in Europe.
• Innovo (Atlantic Therapeutics): Innovo is a neuromuscular electrical stimulation garment/device for stress urinary incontinence, FDA cleared and sold direct-to-consumer. It is the closest direct competitor to Athena's PMT because it uses the same PFES mechanism for the same FDA-cleared indication.

Emerging players

• Renovia: Renovia developed digital therapeutics for female pelvic-floor disorders, including the leva device. It is comparable as a venture-backed women's health startup targeting stress urinary incontinence via intravaginal hardware, though its primary mechanism is biofeedback rather than electrical stimulation.

Broad incumbents

• Axonics: Axonics is a publicly traded commercial-stage medical device company focused on sacral and tibial neuromodulation for urinary and bowel dysfunction. It is a comparable medtech addressing the same end condition (urinary incontinence) via an implantable neuromodulation platform, and represents both a competitive modality and a potential strategic acquirer.
• Cogentix Medical (now part of Laborie): Cogentix Medical (acquired by Laborie) developed the Urgent PC neuromodulation system for urge incontinence. It is comparable as a clinical, minimally invasive alternative for the same patient population Athena targets via at-home electrical stimulation.
• Laborie Medical Technologies: Laborie is a large urology and pelvic-health medical device platform offering diagnostic and therapeutic products for incontinence and pelvic-floor disorders. It is comparable as a broader incumbent serving the same specialist clinician channel Athena targets.

Others

• Embr Labs: Embr Labs is a consumer wearable thermal-stimulation company whose core focus differs from Athena's, but it illustrates the comparable commercial pattern of a small women's-health/wellness hardware startup selling a regulated, app-optional consumer device DTC. Useful as a benchmark for women's-health hardware go-to-market rather than as a clinical competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AthenaPMT
• LinkedInlinkedin.com/company/athena-feminine-technologies-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Athena Feminine Technologies